Effect of heparin drug loading on biodegradable polycaprolactone–iron pentacarbonyl powder blend stents fabricated by solvent cast 3D printing

Abstract

Purpose The purpose of this paper is to fabricate pre-existing geometries of the stents using solvent cast 3D printing (SC3P) and encapsulation of each stent with heparin drug by using aminolysis reaction. Design/methodology/approach The iron pentacarbonyl powder and poly-ɛ-caprolactone blend (PCIP) were used to print stent designs of Art18z, Palmaz-Schatz and Abbott Bvs1.1. The properties of antithrombosis, anticoagulation and blood compatibility were introduced in the stents by conjugation of heparin drug via the aminolysis process. The aminolysis process was confirmed by energy dispersive X-ray spectroscopy and Fourier transform infrared spectroscopy due to presence of amide group and nitrogen peak in the respective analysis. Biological studies were performed to depict the cell viability, hemocompatibility and antithrombotic properties. Besides, mechanical behaviors were analyzed to study the behavior of the stents under radial compression load and bending load. Findings The amount of heparin immobilized on the Art18z, Palmaz-Schatz and Abbott Bvs1.1 stents were 255 ± 27, 222 ± 30 and 212 ± 13 µg, respectively. The cell viability studies using L929 fibroblast cells confirmed the cytocompatibility of the stents. The heparinized SC3P printed stents displayed excellent thrombo-resistance, anticoagulation properties and hemocompatibility as confirmed by blood coagulation analysis, platelet adhesion test and hemolysis analysis. Besides, mechanical behavior was found in context of the real-life stents. All these assessments confirmed that the developed stents have the potential to be used in the real environment of coronary arteries. Originality/value Various customized shaped biodegradable stents were fabricated using 3D printing technique and encapsulated with heparin drug using aminolysis process.